| | FANCD2, LOC107303338 (Q65H) | Single nucleotide variant (missense variant) | Fanconi anemia +4 more | |
| | FANCD2, LOC107303338 (I172M) | Single nucleotide variant (missense variant) | Hereditary breast ovarian cancer syndrome +3 more | |
| | FANCD2, LOC107303338 (T193A) | Single nucleotide variant (missense variant) | Fanconi anemia +2 more | |
| | FANCD2, LOC107303338 (R328Q) | Single nucleotide variant (missense variant) | Fanconi anemia +3 more | |
| | FANCD2, LOC107303338 (L456R) | Single nucleotide variant (missense variant) | Hereditary breast ovarian cancer syndrome +4 more | |
| | FANCD2, LOC107303338 (N545S) | Single nucleotide variant (missense variant +1 more) | Fanconi anemia complementation group A +4 more | |
| | FANCD2, LOC107303338 (P593S +1 more) | Single nucleotide variant (missense variant) | Fanconi anemia complementation group D2 +4 more | GConflicting classifications of pathogenicity |
| | FANCD2, LOC107303338 (Q623P +1 more) | Single nucleotide variant (missense variant) | Fanconi anemia complementation group D2 +5 more | |
| | FANCD2, LOC107303338 (P714L +1 more) | Single nucleotide variant (missense variant) | Hereditary breast ovarian cancer syndrome +5 more | |
| | FANCD2, LOC107303338 (P852L +1 more) | Single nucleotide variant (missense variant) | Fanconi anemia | |
| | FANCD2, LOC107303338 (T856S +1 more) | Single nucleotide variant (missense variant) | not specified | |
| | FANCD2, LOC107303338 (G901V +1 more) | Single nucleotide variant (missense variant) | not specified +4 more | |
| | FANCD2, LOC107303338 (P989A +1 more) | Single nucleotide variant (missense variant) | Fanconi anemia +4 more | |